Structuraland antigenic analysis of a new Rhoptry Pseudokinase Gene (ROP54) in Toxoplasma gondii
Toxoplasma gondii is defined as an obligate intracellular apicomplexan parasite and influences approximatelyone-third of the human all over the world. ROP54 protein is expressed in the rhoptry of Toxoplasma gondii. In the present study, we used SMART software to analyzethe secondary structure of ROP54. The 3D model of ROP54 protein was constructed and analyzed using SWISS-MODEL server and VMD software. The structure results fully showed that ROP54 proteinis an importantmember from the ROP family. Moreover, DNAMAN software and Epitope Database online service were used to analyze liner-B cell epitopes and Th-cell epitopes of the protein. The bioinformatics prediction of ROP54 protein could provide positive information on treatment and vaccine for toxoplasmosis. Furthermore, ROP54 gene was obtained from PCR, and a recombinant eukaryotic expression vector (pEGFP-ROP54) was constructed in the following study. After identification of enzyme digestion, the constructed plasmid was transfected into HEK 293-T cells. The RT-PCR result suggested that the recombinant plasmid could transcribe successfully in HEK 293-T cell.
KeywordsROP54 secondary structures constructed plasmids Toxoplasma gondii
Unable to display preview. Download preview PDF.
- Alaganan A., Fentress S.J., Tang K., Wang Q., Sibley L.D. 2014. Toxoplasma GRA7 effector increases turnover of immunity-related GTPases and contributes to acute virulence in the mouse. Proceedings of the National Academy of Sciences USA, 111, 1126–1131. DOI: 10.1073/pnas.1313501111CrossRefGoogle Scholar
- Bradley P.J., Ward C., Cheng S.J., Alexander D.L., Coller S., Coombs G.H., et al. 2005. Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. Journal of Biological Chemistry, 280, 34245–34258. DOI: 10.1074/jbc.M504158200CrossRefGoogle Scholar
- Butcher B.A., Fox B.A., Rommereim L.M., Kim S.G., Maurer K.J., Yarovinsky F., et al. 2011. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathogens, 7, e1002236. DOI: 10.1371/journal.ppat.1002236CrossRefGoogle Scholar
- Carter J.M., Loomis-Price L. 2004. B cell epitope mapping using synthetic peptides. Current Protocols in Immunology, DOI:10. 1002/0471142735Google Scholar
- Elliot W. Kim., Santhosh M. Nadipuram., Ashley L. Tetlow., William D. Barshop., et al. 2016. The Rhoptry Pseudokinase ROP54 Modulates Toxoplasma gondii Virulence and Host GBP2 Loading. Msphere, 1, e00045-16. DOI: 10.1128/mSphere. 00045-16Google Scholar
- Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., Petersen E. 1999. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infection and Immunity, 67, 6358–6363. DOI: 10.1016/S0960-9822(99)80167-5PubMedPubMedCentralGoogle Scholar
- Wang Y.H., Wang M., Wang G.X., Pang A.N., Fu B.Q., Yin H., et al. 2011. Increasedsurvival time in mice vaccinated with a branched lysine multipleantigenic peptide containing B- and T-cell epitopes from T. gondii antigens. Vaccine, 29, 8619–8623. DOI: 10.1016/j.vaccine.2011.09.016CrossRefGoogle Scholar
- Yamamoto M., Standley D.M., Takashima S., Saiga H., Okuyama M., Kayama H., et al. 2009. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation ofStat3. Journal of Experimental Medicine, 206, 2747–2760. DOI: 10.1084/jem.20091703CrossRefGoogle Scholar